IP Verse

Ascendis Pharma vs. Biomarin Pharmaceutical - UPC_CFI_439/2025

The case UPC_CFI_439/2025 was filed by the plaintiff Ascendis Pharma against the defendant Biomarin Pharmaceutical on 19 May, 2025.

Case Timeline

19 May, 2025
Case Filed
19 May, 2025
Statement of Defence
23 Jul, 2025
Counterclaim for Revocation
Today Nov 1, 2025
Reply Filed
Written Procedure
Oral Procedure
Decision

Case Details

    Case Number:

    UPC_CFI_439/2025

    Patent Number:

    EP3175863

    Filing Date:

    19 May, 2025

    Proceeding Type:

    Counter Claim For Revocation

    Case Phase:

    Written Phase

    Plaintiffs:

    • Ascendis Pharma
    • Ascendis Pharma Growth Disorders

    Plaintiff Representative:

    • Daniel Wise

    Defendants:

    • Biomarin Pharmaceutical

    Defendant Representative:

    • Christian Paul

    Judges:

    • Andras Kupecz
    • Eric AndrĂ© Enderlin
    • Matthias Zigann
    • Tobias Pichlmaier

    Court Division:

    First Instance, Local Division - Munich

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Aug 11, 2025Epo Communication Check Outcome
Jul 30, 2025Scheduling Final
Jul 30, 2025Hearing Dates
Jul 24, 2025Formal Checks Notification Of Positive Outcome
Jul 24, 2025Acknowledgement Of Lodging
Jul 23, 2025Statement Of Defence Against The Counterclaim For Revocation
Jul 23, 2025Exhibit Mr Ar1 Maintained In Opposition
Jul 23, 2025Exhibit Jd 46 Reports On Nep Cleavage Of Larger Peptides
Jul 23, 2025Exhibit Jd 45 Expert Declaration Prof. Wilcox
Jul 23, 2025Exhibit Jd 45 1 Exhibits Prof. Wilcox
Jul 23, 2025Exhibit Jd 39 Expert Declaration Prof. Pasut
Jul 23, 2025Exhibit Jd 39 2 Exhibits Prof. Pasut Part 2
Jul 23, 2025Exhibit Jd 39 1 Exhibits Prof. Pasut Part 1
Jul 23, 2025Exhibit Jd 16 Technology Primer
Jul 23, 2025Exhibit Jd 15 Opposition Decision EP863
Jul 23, 2025Exhibit Jd 13 EP3175863B1
Jul 23, 2025Exhibit Ar 4 Mr And Disclaimer
Jul 23, 2025Exhibit Ar 3 Conjugate Without Linkage Complete
Jul 23, 2025Exhibit Ar 2 Conjugate Without Linkage In Claim 1
Jul 23, 2025Exhibit Ar 1 Conjugate
Jul 23, 2025Biomarin VS Ascendis Application To Amend A Patent
Jul 23, 2025Acknowledgement Of Lodging
Jul 8, 2025Panel Appointment
Jun 26, 2025Notification Of Service
Jun 26, 2025Access To Case
Jun 11, 2025Acknowledgement Of Access To Case
May 28, 2025Document From Epo
May 27, 2025Panel Appointment
May 27, 2025Letter For Service
May 27, 2025Formal Checks Notification Of Positive Outcome
May 27, 2025Epo Request For Case Pending
May 27, 2025Acknowledgement Of Lodging
May 19, 2025Statement Of Defence
May 19, 2025Proof Of Payment
May 19, 2025Exhibit CR 48
May 19, 2025Exhibit CR 48
May 19, 2025Exhibit CR 47
May 19, 2025Exhibit CR 46
May 19, 2025Exhibit CR 45
May 19, 2025Exhibit CR 44
May 19, 2025Exhibit CR 43
May 19, 2025Exhibit CR 42
May 19, 2025Exhibit CR 41
May 19, 2025Exhibit CR 40
May 19, 2025Exhibit CR 39
May 19, 2025Exhibit CR 39
May 19, 2025Exhibit CR 39
May 19, 2025Exhibit CR 39
May 19, 2025Exhibit CR 38
May 19, 2025Exhibit CR 37
May 19, 2025Exhibit CR 36
May 19, 2025Exhibit CR 35
May 19, 2025Exhibit CR 34
May 19, 2025Exhibit CR 33
May 19, 2025Exhibit CR 32
May 19, 2025Exhibit CR 31
May 19, 2025Exhibit CR 31
May 19, 2025Exhibit CR 30
May 19, 2025Exhibit CR 29
May 19, 2025Exhibit CR 23
May 19, 2025Exhibit CR 22
May 19, 2025Exhibit CR 21
May 19, 2025Exhibit CR 20
May 19, 2025Exhibit CR 19
May 19, 2025Exhibit CR 18
May 19, 2025Exhibit CR 17
May 19, 2025Exhibit CR 17
May 19, 2025Exhibit CR 16
May 19, 2025Exhibit CR 15
May 19, 2025Exhibit CR 14
May 19, 2025Exhibit CR 13
May 19, 2025Exhibit CR 12
May 19, 2025Exhibit CR 11
May 19, 2025Exhibit CR 10
May 19, 2025Exhibit CR 09
May 19, 2025Exhibit CR 08
May 19, 2025Exhibit CR 07
May 19, 2025Exhibit CR 06
May 19, 2025Exhibit CR 05
May 19, 2025Exhibit CR 04
May 19, 2025Exhibit CR 03
May 19, 2025Exhibit CR 02
May 19, 2025Exhibit CR 01

More cases involving EP3175863B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_33004/2025Jul 23, 2025Biomarin PharmaceuticalAscendis Pharma, Ascendis Pharma Growth Disorders
CC_23597/2025May 19, 2025Ascendis Pharma, Ascendis Pharma Growth DisordersBiomarin Pharmaceutical
ACT_1613/2025Jan 13, 2025Biomarin PharmaceuticalAscendis Pharma, Ascendis Pharma Growth Disorders

More cases involving Ascendis Pharma

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
CC_23597/2025May 19, 2025Ascendis Pharma, Ascendis Pharma Growth DisordersBiomarin Pharmaceutical
APP_13067/2025Mar 18, 2025Ascendis Pharma, Ascendis Pharma Growth DisordersBiomarin Pharmaceutical

More cases involving Biomarin Pharmaceutical

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_33004/2025Jul 23, 2025Biomarin PharmaceuticalAscendis Pharma, Ascendis Pharma Growth Disorders
CC_23597/2025May 19, 2025Ascendis Pharma, Ascendis Pharma Growth DisordersBiomarin Pharmaceutical
APP_13067/2025Mar 18, 2025Ascendis Pharma, Ascendis Pharma Growth DisordersBiomarin Pharmaceutical